According to OKYO Pharma's latest financial reports the company's current EPS (TTM) is -โน42.40. In 2022 the company made an earnings per share (EPS) of -โน42.40 an increase over its 2021 EPS that were of -โน55.70.
Year | EPS | Change |
---|---|---|
2022 | -โน42.40 | -23.88% |
2021 | -โน55.70 | 285.65% |
2020 | -โน14.44 | -71.55% |
2019 | -โน50.77 | -87.01% |
2018 | -โน390.92 | 3917.84% |
2017 | -โน9.73 | -18.97% |
2016 | -โน12.01 | -90.16% |
2015 | -โน122.07 | -52.63% |
2014 | -โน257.70 | 181.93% |
2013 | -โน91.40 | 3547.06% |
2012 | -โน2.51 | -90.67% |
2011 | -โน26.86 | -112.7% |
2010 | โน211.41 | -14.64% |
2009 | โน247.67 | -183.01% |
2008 | -โน298.37 |